Now in its fourth year, this two-day symposium has been planned for the providers of care to patients with rheumatic diseases. Given the wide variety of rheumatologic disorders, and an ever-increasing number of diagnostic procedures and treatment options, it is necessary to provide clinicians with information about strategies for the early diagnosis of these conditions, novel state-of-the-art diagnostic tools, and opportunities to utilize the most effective treatments to ensure optimal patient outcomes.
Date: June 6th & 7th, 2008
Don’t have SilverLight? Get it here.
- Advances in Understanding and Treatment of Psoriatic Arthritis
- Vitamin D Deficiency and the Rheumatologist: What Should We Know?
- Treating JIA for Remission
- Aging: An Inflammatory disease
- Sjogren’s Syndrome
- Inflammatory Bowel Disease for the Rheumatologist
- Fibromyalgia: Applying New Insights in Pathophysiology to New Treatment Approaches
- The Lyme Disease Controversy
- Health Disparities in Rheumatic Disease
- Rheumatoid Arthritis: Treatment Approaches
- Interstitial Lung Disease 2008: The Lung as an End Organ in Rheumatic Disease
- Myositis
- Neurology for the Rheumatologist
- The Academy Awards in Vasculitis
- Amyloidosis: Advances in Diagnosis and Prognosis
- Immunoablative Strategies in the Rheumatic Diseases
- Dermatology for the Rheumatologist
Policy On Speaker And Provider Disclosure
It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.
